RARE DISCOVERY CONSULTING
STEWARDSHIP CHARTER
Version 1.0 | November 3, 2026

PURPOSE AND CURRENT STAGE
We are building a faith-guided investment and venture-building platform
focused on technology that advances human flourishing through healthcare,
work, education, and essential services. This charter sets foundational
commitments for that work; it does not certify an established investment
process or report investment results.

1. PROTECT HUMAN DIGNITY
Consider patients, workers, students, and communities alongside customers
and shareholders. Examine access, affordability, privacy, and the
consequences of automation.

2. PRACTICE FINANCIAL STEWARDSHIP
Match spending and growth ambitions to available resources. Evaluate
financial sustainability, time horizons, and downside risk alongside the
intended benefit.

3. TELL THE TRUTH
Substantiate product and impact claims. Describe our role in each venture
accurately, make conflicts visible, and acknowledge what the evidence
does not yet show.

4. DISCLOSE CONFLICTS OF INTEREST
Make ownership, advisory, and financial relationships clear. Where
interests overlap, identify the conflict and establish an appropriate
review before committing capital.

5. LEAD THROUGH SERVICE
Listen to the people affected by a product. Seek fair treatment, channels
for concerns, and a willingness to correct decisions that cause harm.

6. RESPECT FREEDOM OF CONSCIENCE
Our Christian faith guides our conduct. Our commitment to dignity extends
to people of every faith and none, without religious pressure on employees
or customers.

WHERE WE DRAW THE LINE
We will decline opportunities whose business model depends on deception,
exploitation, coercion, or misuse of personal data. When a product creates
risks for workers or vulnerable people, a credible plan to address those
risks is part of the investment case.

MEASUREMENT
Our proposed measures pair commercial progress with human outcomes. We
intend to tailor measures to each venture, identify baselines, and examine
both benefits and harms. Proposed measures are not portfolio results.

QUESTIONS AND CONCERNS
Contact info@rarediscoveryconsulting.com to discuss these commitments or
raise a concern. Future revisions should identify their version and date.